Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Overweight on Equifax, Lowers Price Target to $273

Author: Benzinga Newsdesk | April 19, 2024 08:15am
JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:EFX) with a Overweight and lowers the price target from $290 to $273.

Posted In: EFX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist